Skip to main content

Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS)

CRIPS is a research group focusing on severe acute respiratory infections and sepsis. 

The objective is to develop projects on clinical and translational research in hospital-acquired pneumonia, community-acquired pneumonia, and severe viral respiratory infections, such as influenza and COVID-19. CRIPS also develop epidemiological studies focused on risk and prognostic factors for multi-resistant pathogens, validation of ventilator-associated events in ventilated adult and pediatric patients, incorporating artificial intelligence techniques. It also highlights evidence-based medicine (EBM) research, evaluating therapies and prevention strategies and participating in the formulation of clinical practice guidelines, as part of CIBERES and the European Society for Clinical Microbiology and Infections. The EBM research focuses on knowledge translation to get research findings to the point of decision making, providing health-related recommendations, focusing on clinical research and relevance of care. 

CRIPS collaborate on a Local (UIC, IDIAP), National (CIBERES), and International level (CHU Nimes, Uolo University, ISARIC and Pneumo-Inspire Networks).

Publications

A novel id-iri score: development and internal validation of the multivariable community acquired sepsis clinical risk prediction model.

PMID: 31823148
Journal: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Year: 2020
Reference: Eur J Clin Microbiol Infect Dis. 2020 Apr;39(4):689-701. doi: 10.1007/s10096-019-03781-y. Epub 2019 Dec 10.
Impact factor: 2.837
Publication type: Paper in international publication
Authors: Diktas, Husrev, Uysal, Serhat, Erdem, Hakan, Cag, Yasemin, Miftode, Egidia, Durmus, Gul, Ulu-Kilic, Aysegul, Alabay, Selma, Szabo, Balint Gergely, Alexandru, Crisan et al.
DOI: 10.1007/s10096-019-03781-y

Parvovirus B19 Myocarditis: Looking Beyond the Heart.

PMID: 31335286
Journal: PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
Year: 2020
Reference: Pediatr Dev Pathol. 2020 Mar-Apr;23(2):158-162. doi: 10.1177/1093526619865641. Epub 2019 Jul 23.
Impact factor: 0.885
Publication type: Paper in international publication
Authors: Izquierdo-Blasco, Jaume, Salcedo Allende, Maria Teresa, Codina Grau, Maria Gemma, Gran, Ferran, Martinez Saez, Elena, Balcells, Joan et al.
DOI: 10.1177/1093526619865641

Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients-a randomized clinical trial.

PMID: 32131866
Journal: CRITICAL CARE
Year: 2020
Reference: Crit Care. 2020 Mar 4;24(1):74. doi: 10.1186/s13054-020-2792-z.
Impact factor: 6.407
Publication type: Paper in international publication
Authors: Schneider, Hauke, Kanesa-Thasan, Niranjan, Eder-Lingelbach, Susanne, Klingler, Anton, Dubischar, Katrin, Wressnigg, Nina, Rello, Jordi, Sramek, Vladimir, Hejja, Maria, Schaaf, Bernhard et al.
DOI: 10.1186/s13054-020-2792-z

Coronavirus Disease 2019 (COVID-19): A critical care perspective beyond China.

PMID: 32142972
Journal: Anaesthesia Critical Care & Pain Medicine
Year: 2020
Reference: Anaesth Crit Care Pain Med. 2020 Apr;39(2):167-169. doi: 10.1016/j.accpm.2020.03.001. Epub 2020 Mar 3.
Impact factor: 2.707
Publication type: Editorail in international publication
Authors: Pugin, Jerome, Waterer, Grant, Arvaniti, Kostoula, Userovici, Caroline, Tejada, Sofia, Rello, Jordi et al.
DOI: 10.1016/j.accpm.2020.03.001

Blog

News

A study, in which Vall d'Hebron has participated, has analysed all the interventions of this type carried out between 2006 and 2020.

The work of the multinational team, which has reviewed the records of more than one million patients who have received a new organ, has found significant differences between women and men

The scientific review reports that changes in the respiratory system flora due to pollution increase the risk of suffering a hospital infection caused by multidrug-resistant organisms.